Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-CD20, Chimeric Antibody (R3)

Biosimilar to Rituximab, monoclonal antibody that targets CD20
Catalog #: A1049
$435.00

Product Details

Cat # +Size A1049-100
Size 100 µg
Antibody Target CD20
Host Recombinant
Antibody Type Monoclonal
Isotype Human IgG1
Immunogen CD20
Accession # P11836
Gene ID 54474
Appearance Colourless liquid
Formulation In Phosphate buffered saline, pH 7.4.
Purification Protein A chromatography.
Species Reactivity Human
Application Neutralization, ELISA
Application & Usage Neutralization: 1-20 μg/ml; ELISA: 2μg/ml
Handling The antibody solution should be gently mixed before use.
Storage Conditions Store at -20℃. Once thawed, keep it at 4℃
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

This biosimilar is a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. CD20 plays a role in B lymphocyte development, differentiation, and activation, and is usually expressed on pre- and mature B lymphocytes, as well as malignant B lymphocytes. The Fab domain of the antibody binds to the large and small extracellular loops of the CD20.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.